tiprankstipranks
Restart Life Sciences (NMLSF)
OTHER OTC:NMLSF
Holding NMLSF?
Track your performance easily

Restart Life Sciences (NMLSF) Technical Analysis

20 Followers

Summary of all the Indicators

Overall Consensus
Sell
3Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
9Bearish
Restart Life Sciences’s (NMLSF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Restart Life Sciences is a Sell.
Restart Life Sciences’s (NMLSF) 20-Day exponential moving average is 0.02, while Restart Life Sciences’s (NMLSF) share price is <$0.1, making it a Sell.
Restart Life Sciences’s (NMLSF) 50-Day exponential moving average is 0.04, while Restart Life Sciences’s (NMLSF) share price is <$0.1, making it a Sell.

Restart Life Sciences (NMLSF) Pivot Points

Dec 23, 2024, 02:40 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Fibonacci
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Restart Life Sciences (NMLSF) Moving Averages

Dec 23, 2024, 02:40 PM
Period
Simple
Exponential
MA5
0.02Buy
0.02Sell
MA10
0.02Sell
0.02Sell
MA20
0.02Sell
0.02Sell
MA50
0.04Sell
0.04Sell
MA100
0.05Sell
0.05Sell
Restart Life Sciences’s (NMLSF) 10-Day exponential moving average is 0.02, while Restart Life Sciences’s (NMLSF) share price is <$0.1, making it a Sell.
Restart Life Sciences’s (NMLSF) 100-Day exponential moving average is 0.05, while Restart Life Sciences’s (NMLSF) share price is <$0.1, making it a Sell.
Restart Life Sciences’s (NMLSF) stock price is <$0.1 and Restart Life Sciences’s (NMLSF) 50-day simple moving average is 0.04, creating a Sell signal.
Restart Life Sciences’s (NMLSF) stock price is <$0.1 and Restart Life Sciences’s (NMLSF) 100-day simple moving average is 0.05, creating a Sell signal.

Restart Life Sciences (NMLSF) Technical Indicators

Dec 23, 2024, 02:40 PM
Name
Value
Implied Action
RSI (14)
40.43
Neutral
STOCH (9,6)
33.86
Neutral
STOCHRSI (14)
25.88
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
21.25
Neutral
Williams %R
-73.68
Buy
CCI (14)
-81.82
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
71.67
Buy
ROC
0.00
-
Restart Life Sciences’s (NMLSF) Relative Strength Index (RSI) is 40.43, creating a Neutral signal.
Restart Life Sciences’s (NMLSF) Trend Strength Indicator (ADX) is 21.25, creating a Neutral signal.
Restart Life Sciences’s (NMLSF) Commodity Channel Index (CCI) is -81.82, creating a Neutral signal.

FAQ

Is NMLSF a Buy, Hold, or Sell?
Based on NMLSF’s technical indicators, NMLSF is a Sell.
    What is NMLSF’s RSI (14)?
    NMLSF’s RSI (14) is 40.43, which suggests NMLSF is a Neutral.
      What is NMLSF’s MACD?
      NMLSF’s MACD is >-0.01, which suggests NMLSF is a Sell.
        What is NMLSF’s 5-day moving average?
        NMLSF’s 5-day moving average is 0.02, which suggests NMLSF is a Buy.
          What is NMLSF’s 20-day moving average?
          NMLSF 20-day moving average is 0.02, which suggests NMLSF is a Sell.
            What is NMLSF’s 50-day moving average?
            NMLSF’s 50-day moving average is 0.04, which suggests NMLSF is a Sell.
              What is NMLSF’s 200-day moving average?
              Currently, no data Available
              What is NMLSF’s Williams % R (14)?
              NMLSF’s Williams % R (14) is -73.68, which suggests NMLSF is a Buy.
                What is NMLSF’s CCI (14)?
                NMLSF’s CCI (14) is -81.82, which suggests NMLSF is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis